These patients require surgery with multiple excisions, each of which can have complications such as hematoma necessitating further surgery.BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium) has the option to exclusively license development and marketing rights to the human lipoma indication following completion of a new trial, which would trigger an opt-in payment and pote